Vasilios Kofitsas
Get their honest, personalized take on your startup.
Sign in to pitch Vasilios →At a glance
- Full Name
- Vasilios M. Kofitsas
- Title
- Partner, Managing Director, Investment Banking
- Firm
- Back Bay Life Science Advisors (BBLSA)
- Firm Type
- Life science strategy consulting & healthcare investment banking / financial advisory (not a traditional angel or venture fund — see note below)
- Investment Stage
- Works across the corporate lifecycle of biotech, pharma and medtech companies — private and public — primarily on growth-, transaction- and exit-stage financing and M&A rather than seed/angel checks
- Check Size
- Not applicable / not publicly disclosed — BBLSA advises on and executes client transactions (equity raises, M&A, licensing) rather than investing its own balance sheet
- Target Company Profile
- Biotechnology, pharmaceutical, and medical technology / diagnostics companies and their investors
- Sector Focus
- Life sciences — biopharma, medical devices, diagnostics
- Geographic Focus
- Primarily U.S., with global life-science transaction work
- Location
- Boston, Massachusetts (545 Boylston Street, 12th Floor, Boston, MA 02116)
Background
Vasilios M. Kofitsas is a Partner and Managing Director in Investment Banking at Back Bay Life Science Advisors, a Boston-based integrated strategy-consulting and healthcare investment-banking firm serving the life sciences. He brings roughly two decades of experience in strategy and corporate finance for biotech, pharmaceutical, and medical technology companies, and joined BBLSA at the firm's inception, helping build out its transaction-advisory and corporate-finance capabilities.
Before Back Bay, Kofitsas served as Vice President, Healthcare Investment Banking at Oppenheimer & Co., and earlier as Senior Associate, Investment Banking at Leerink Swann & Company (now Leerink Partners / SVB Leerink), where he was part of the team that established the firm's corporate finance and advisory practice. Across these roles he has completed transactions spanning equity capital raises and M&A/licensing, working both the buy side and sell side.
He holds a BS degree from Babson College and is a Series 7 and Series 63 Registered Securities Representative. Within BBLSA, his work concentrates on corporate growth, transaction strategy, and execution — including mergers and acquisitions, in- and out-licensing deals, and strategic collaborations — for companies and investors in the biopharma, medtech, and diagnostics sectors.
Investment Thesis & Focus
- Operates as a healthcare investment banker / strategic advisor, not as a personal angel or fund GP — the "yes" here is a decision to *advise on or run a transaction*, not to write a personal check.
- Sector concentration is firmly in life sciences: biotech, pharmaceutical, medical technology, and diagnostics companies and their investors.
- Focus areas are corporate growth, transaction strategy, and execution — M&A (buy- and sell-side), licensing and collaboration deals, and equity financings.
- BBLSA's stated value proposition is integrated strategy consulting + investment banking for the life sciences, guiding companies on development, commercialization, growth, and value maximization through transactions and capital events.
Notable Investments
No personal portfolio of angel/seed investments was found in public sources. As an investment banker, Kofitsas's "deals" are client transactions (equity raises, M&A, and licensing/collaborations) executed through Back Bay Life Science Advisors, Oppenheimer & Co., and Leerink Swann. Specific named transactions attributable to him individually are not publicly disclosed, so none are listed here to avoid fabrication.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.